Author:
Yan Yan,Jiang Guozhong,Ma Weijie,Li Tianhong,Wang Liping
Funder
University of California, Davis
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference34 articles.
1. Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC);Gelatti,2019
2. Acquired resistance to TKIs in solid tumours: learning from lung cancer;Camidge,2014
3. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;Yu;Clin Cancer Res,2013
4. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer;Mok;N Engl J Med,2017
5. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer;Leonetti;Br J Cancer,2019
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献